Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.137
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.772
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.962
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.964
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:87m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:151m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
1.49×10-07
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.156
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
4.25×10-08
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.824
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.000293
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00327
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
2.08×10-12
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.389
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.128
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.559
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.000406
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.407
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0938
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.333
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.148
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.158
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00609
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.808
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.56×10-05
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0743
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
6.80×10-06
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.473
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.690
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.856
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.376
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.678
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.00
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0604
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0127
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.962
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:87m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:151m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
1.40×10-05
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.116
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.412
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.560
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.450
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.605
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0307
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.605
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.200
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.545
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.233
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.594
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
1.58×10-05
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0280
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0384
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.141
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HET
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.592
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.933
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:20m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0731
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.923
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.00106
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.177
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.812
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.906
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.00118
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0577
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.546
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.800
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:151m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:87m
|
|
|
NotProcessed |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0733
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.342
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.000722
|
Successful |
Cxcr2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.655
|
Successful |